Robert L. Grossman

Robert L. Grossman: Attorney with Greenberg Traurig, LLP
  • Shareholder; Co-Chair, Israel Practice at Greenberg Traurig, LLP (1800 Attorneys)
  • 333 SE 2nd Avenue, Suite 4400, Miami, FL 33131
    View Robert L. Grossman's office location
  • Peer Reviews
    Client Reviews
    No Reviews
  • Profile Visibility [ i ]


Bob Grossman is Co-Chair of the Israel Practice and began practicing securities, M&A and corporate law in the firm's Miami office in 1982. With wide-ranging experience taking companies public, acquiring and selling companies, and as a business advisor, Bob brings a practical business-oriented approach to his clients' problems, focusing on accomplishing his clients' objectives effectively and efficiently. He has represented a diverse collection of public and private companies, including companies in the medical device, pharmaceutical, biotechnology, ag-tech, health care, energy and natural resources, technology and software, and communications industries.

As the Co-Chair of the firm's Israel Practice and is a frequent business visitor to Israel. In addition to representing Israeli companies seeking to do business outside of Israel, the firm's Israel Practice Group provides assistance to Israeli and U.S. companies in all legal aspects as well as through introductions to strategic partners.


•Public and Private Offerings
•Mergers and Acquisitions
•Pharma and Medical Device
•Agriculture and Ag-tech
•Israeli Businesses
•Other Diverse Industry Representations

Recognition & Leadership

Awards & Accolades

•Selected, Daily Business Review, Top Dealmaker of the Year - Corporate Domestic Category, 2016
•Listed, South Florida Legal Guide, Top Lawyer, 2007-2016
•Listed, Chambers Global, Corporate/M&A (Foreign Experts - USA and Experts Based Abroad - Israel), 2011-2017
•Recognized, BDICoface 2016-2017 (Israel) , International Commercial - Outstanding Leaders, 2016-2017
•Recognized, Dun’s 100, 2016-2017 (Israel) , International Commercial - Prominent Team, 2016-2017
•Recognized, IFLR , Corporate & M&A,Israel, Other Notable, 2017
•Recognized, The Legal 500: Europe, Middle East & Africa Israel: Commercial, corporate and M&A, 2017
•Selected, Life Science Star, LMG Life Sciences, 2016
•Listed, Martindale-Hubbell and ALM, 2013 Top Rated Lawyer - Securities Law, 2013
•Team Member, Corporate Board Member magazine and FTI Consulting Inc., one of America’s Best Corporate Law Firms, 13th Annual Legal Industry Study, 2013
•Listed, Chambers & Partners USA Guide, Top Corporate/M&A Lawyer in Florida, 2006-2008, 2013
•Member, team ranked as a top corporate law firm in Miami as selected by corporate directors, in the annual Legal Industry Research Study by Corporate Board Member magazine and FTI Consulting Inc. (10th year), 2002-2009, 2011-2012
•Finalist, Daily Business Review, Top Dealmaker of the Year - Corporate (Domestic) Category, 2012
•Recommended, PLC Which Lawyer? Yearbook, 2009
•Listed, Super Lawyers magazine, Florida Super Lawyers, 2006
•Listed, Daily Business Review, South Florida's Top Dealmakers of the Year in Mergers & Acquisitions, 2005
•Recipient, Put Something Back Corporate Award, Eleventh Judicial Circuit and Dade County Bar Association, 2003
•Recipient, Greater Miami Jewish Federation
• Stanley C. Myers Presidents' Leadership Award, 1999
• Robert Russell Leadership Award, 1998
•Listed, South Florida Business Review, Most Effective Lawyers
•Rated, AV Preeminent 5.0 out of 5

AV , AV Preeminent , Martindale-Hubbell Distinguished and Martindale-Hubbell Notable are certification marks used under license in accordance with the Martindale-Hubbell certification procedures, standards and policies.

Areas of Practice (6)

  • Corporate
  • Life Sciences & Medical Technology
  • Health Care & FDA Practice
  • Technology, Media & Telecommunications
  • Emerging Technology
  • Real Estate Finance

Education & Credentials

Contact Information:
305.579.0756  Phone
305-961-5756  Fax
University Attended:
The Ohio State University, M.A., Recipient Ohio State University Fellow, 1979; The Ohio State University, B.A., Recipient Esteemed Senior Award, 1975
Law School Attended:
The Ohio State University Moritz College of Law, J.D., with honors, Order of the Coif
Year of First admission:
1978, Ohio; 1982, Florida

Professional & Community Involvement

•Committee member, Temple Beth Am Israel
•Member, Greater Miami Jewish Federation, Yerucham Development Committee, 2007-2013
•Board Member, Board of Directors and Executive Committee
•Chairman, Agency, Day School and Synagogue Campaign, 2003-2005
•Past Chairman, South Dade Branch
•Board Member, Project Interchange, Board of Directors, 2005-2013
•Board Member, Jewish National Fund, Board of Directors, 2005-Present
•Board Member, Children's Bereavement Center, Board of Directors, 2001-Present
•Board Member, Temple Beth Am, Board of Directors, 2003-2005
•Chairman, Executive Institute of Organization for Leadership Advancement in Miami, 2001-2003
•Chairman, South Dade Israel Task Force (formed first Victims of Terror in Israel Fund and developed South Dade Israel Awareness Week), 2001-2003
•Member, Florida Bar, Corporate Law Subcommittee, 1995-1997
•Member, American Bar Association
•Member, Dade County Bar Association
•Past Chairman and Co-Founder, South Dade Jewish Leadership Council
•Past Chairman, National UJA Young Leadership Cabinet, Miami Division
•Past Member, Dave and Mary Alper Jewish Community Center, Board of Directors and Executive Committee
•Past Member, The Beacon Council, Executive Committee

Birth Information:
Cleveland, Ohio, December 20, 1954
Reported Cases:
Experience: Representative Matters:; Represent Integrity Applications in various private placements, represent Autobrain in private placements, Represent Intec Pharma Ltd. in a $10 million private placement; Represented a Japanese public technology company in the acquisition of an Israeli technology company for over $200 million.; Representing a leading pharmaceutical company in a $2.3 billion acquisition.; Represented OPKO Health, Inc. in the $1.4 billion acquisition of Bioreference Labs.; Represented Intec Pharma Ltd. in its initial public offering.; Represented Scivac Ltd. in its merger with Levon Resources Ltd.; Representing Scivac Ltd. in its acquisition of VBI Vaccines Inc.; Represented numerous U.S., Israeli and other private life science and technology companies in various private placements.; Represented Orbimed Israel in registered direct investment in BiolineRx, Ltd.; Represented Orbimed Israel in PIPE investment in Red Hill BioPharma Ltd.; Representing Galmed Pharmaceuticals, Ltd. in its initial public offering.; Represented Prolor Biotech, Inc. in its acquisition by OpKo Health, Inc.; Represented Castle Brands, Inc. in an ATM offering.; Represented Glasses Off, Inc. in a reverse merger and private placement pursuant to which the Company went public.; Represented OPKO Health, Inc. in an investment in RXI Pharmaceuticals and the transfer of certain technology and sale of certain assets to RXI.; Represented Israeli pharmaceutical company Immune Pharmaceuticals Ltd. in a reverse triangular merger with EpiCept Corporation, a U.S. and Swedish publicly traded biopharmaceutical company, whereby Immune became a wholly owned subsidiary of, and Immune's shareholders obtained a controlling interest in, EpiCept, which is now known as Immune Pharmaceuticals Inc.; Represented Enlivex Therapeutics Ltd. in various private placements.; Represented Prolor Biotech, Inc. in a public offering.; Represented a mobile virtual network operator (MVNO), a subsidiary of a public company, with its approximately $120 million acquisition of substantially all of the assets and assumption of certain of the liabilities of another MVNO that provides prepaid SIM cards to its customers.; Represented Integrity Applications, Inc. in becoming a publicly reporting company.; Represented an Israeli pharmaceutical company in listing Level II ADRs.; Represented Castle Brands, Inc., developer and international marketer of premium and super premium alcoholic beverage brands, in a private placement (PIPE) of convertible preferred stock and warrants to various investors, including the conversion of various tranches of the issuer's existing debt into preferred stock.; Represented the representative of the shareholders of Beeologics in its sale of all the stock of Beeologics Holdings Limited, a Cyprus entity, and Beeologics, Inc., a BVI entity, to Monsanto Company.; Represented OPKO Health, Inc. (NYSE: OPK) in connection with its acquisition of Claros Diagnostics, Inc. a private company engaged in the development and marketing of medical diagnostic devices.; Represented Ladenburg Thalmann Financial Services, Inc. in its acquisition of Securities America and its subsidiaries.; Represented IVAX Corporation in its merger with TEVA Pharmaceutical Industries Ltd.; Represented Frost Group in investment in Protalix and in the transaction by which Protalix became a public company.; Represents various life science companies in license and distribution agreements and corporate transactions and matters.; Represents various public companies as outside securities counsel.; Represented UBS in a public offering of Protalix Ltd.; Represented Devcon International Corp. in its acquisition of Adelphia electronic security services assets.; Represented Orthodontix, Inc. and The Frost Group in a reverse merger with and investment into Protalix Ltd. pursuant to which Protalix became a publicly reporting company.; Represented various underwriters in public offerings, including public offerings of Israeli companies.

Peer Reviews

  • 5.0/5.0
  • A Martindale-Hubbell Peer Rating reflects a combination of achieving a Very High General Ethical Standards rating and a Legal Ability numerical rating.

*Peer Reviews provided before April 15, 2008 are not displayed.

Client Reviews

This attorney does not have client reviews.

Documents ({{amountArticles}})

Documents by this lawyer on
Other documents: ,

Miami, Florida

Contact Robert L. Grossman

Please correct the fields highlighted in red.

By clicking on the "Submit" button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Martindale and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.